
LMT · NYSE
Expected to report Jan 28, 2027 — estimated from last year’s reporting date.
Consensus is $8.40 EPS for Dec 2026 across 6 estimates, ranging $8.20 to $8.65.
Lockheed Martin delivered a broad-based growth quarter, with Q3 sales of $20.71 billion up 11.3% year over year and 3.2% sequentially. Diluted EPS of $7.97 beat the $7.49 consensus by 6.4%, compared with $6.95 in Q3 2025 and $7.94 in Q2 2026. Net earnings rose 14% year over year to $1.85 billion. Consolidated operating profit increased to $2.44 billion from $2.28 billion a year ago, although it was below Q2’s $2.48 billion; the consolidated operating margin was 11.8%, versus 12.3% a year ago.
The print was defined by accelerating weapons production, a sharp step-up in backlog and another upward revision to full-year guidance. Missiles and Fire Control grew fastest as PAC-3, THAAD, GMLRS and PrSM production ramped, while Aeronautics also benefited from F-35 volume. Backlog rose to a record $292.0 billion, including $52.5 billion from the PAC-3 MSE multi-year award. Management raised the 2026 EPS midpoint to $30.55 from $30.30 and the free-cash-flow midpoint to $7.9 billion from $7.1 billion. The strong orders and earnings came alongside lower year-over-year quarterly cash flow and a specific funding exposure on F-35 Lot 20.
The strongest growth came from Missiles and Fire Control, where sales rose 24% to $4.50 billion and operating profit increased 24% to $631 million. Production ramps in PAC-3 and THAAD added about $480 million of sales, while GMLRS and PrSM added about $330 million. The resulting demand is also visible in backlog: it increased $61.6 billion during the quarter to a record $292.0 billion, driven primarily by the $52.5 billion PAC-3 MSE multi-year award. Lockheed expects to recognize about 23% of backlog as revenue over the next 12 months and 40% over the next 24 months.
Lockheed raised its outlook for the second consecutive quarter. The new sales range is approximately $80–82 billion, versus $79.75–81.75 billion previously, and diluted EPS is now $30.35–30.75 versus $29.95–30.65. The free-cash-flow range increased to $7.8–8.0 billion from $7.0–7.2 billion, alongside higher cash-from-operations guidance of $10.0–10.2 billion versus $9.2–9.4 billion. The business-segment operating-profit range is now $8.575–8.675 billion, compared with $8.5–8.7 billion. The guidance increase reflects the company’s stronger operating momentum and cash outlook.
Q3 cash from operations was $3.44 billion and free cash flow, which Lockheed defines as operating cash flow less capital expenditures, was $3.00 billion. Both were lower than a year ago, when they were $3.73 billion and $3.35 billion, respectively; management attributed the declines primarily to higher customer receipts in Q3 2025. The company spent $439 million on capital expenditures in the quarter and $599 million on independent research and development. Cash and cash equivalents were $5.96 billion at quarter-end.
The company remains in negotiations with the U.S. Government on production contracts for F-35 Lots 20 and higher. During Q3, costs incurred on the Lot 20 advance-acquisition contract began to exceed current contractual authorization and funding. Lockheed said results, cash flows and financial condition could be negatively affected in future periods without additional authorization and funding. Aeronautics delivered 43 F-35 aircraft in the quarter, compared with 46 a year earlier; cumulative production deliveries reached 1,387, with a backlog of 274 aircraft.